After completing medical school and residency, Dr. Sherry Farzan returned to Long Island, where she grew up, to pursue training in allergy and immunology. As a fellow, she noticed how her patients with asthma would respond differently to the same medications. She was also intrigued by the co-burgeoning epidemics of asthma and obesity. She has therefore sought out to clarify the relationship between asthma and obesity, and is studying the role of different medications, which may be more effective in the obese asthmatic. She has completed a randomized trial to evaluate if montelukast may be a more effective controller medication than the first line inhaled corticosteroids in obese asthmatics. Currently she is recruiting for a study to assess the molecular basis of differences in medication response in obese versus lean asthmatics.
Differential medication responses in obese versus lean asthmatics, molecular basis of asthma in the obese, and the role of vitamin D in chronic urticaria.
Harvard Medical School